Five years after the first cases of COVID-19, reports of hMPV, an obscure respiratory virus in China may understandably raise ...

If you don't know your blood type, you're not alone. However it is important medical information to know, and here's how you ...

Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

Thanks to an innovative method of super-resolution microscopy, researchers from the University of Würzburg have observed ...

Respiratory illnesses are on the rise across San Antonio, Bexar County and Texas. Doctor Jason Bowling, a professor and infectious diseases specialist at UT Health San Antonio and the Chief ...

The application is supported by data from the randomized, double-blind, placebo-controlled phase 3 Vivacity-MG3 study.

In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

Alchemab Therapeutics, a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies ...

Universal Ostrich has approximately 400 birds and is located in the Regional District of Central Kootenay (RDCK), east of ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.